A Mini-Review of In Vitro Data for <i>Candida</i> Species, Including <i>C. auris,</i> Isolated during Clinical Trials of Three New Antifungals: Fosmanogepix, Ibrexafungerp, and Rezafungin

This mini-review summarizes the clinical outcomes and antifungal susceptibility results, where available, for three new antifungals, including fosmanogepix, ibrexafungerp, and rezafungin, against <i>Candida</i> isolates cultured from patients in clinical trials. When reported, most of the data were...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ana Espinel-Ingroff, Nathan P. Wiederhold
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2024-05-01
Saila:	Journal of Fungi
Gaiak:	fosmanogepix ibrexafungerp rezafungin <i>Candida</i> species clinical trials in vitro activity
Sarrera elektronikoa:	https://www.mdpi.com/2309-608X/10/5/362
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!